Sawicki P T, Didjurgeit U, Mühlhauser I, Bender R, Heinemann L, Berger M
Department of Nutrition and Metabolic Diseases, World Health Organization, Collaborating Center for Diabetes, Heinrich-Heine University, Düsseldorf, Germany.
Diabetes Care. 1994 Feb;17(2):126-31. doi: 10.2337/diacare.17.2.126.
To investigate the association between cigarette smoking and the progression of diabetic nephropathy.
A prospective, follow-up study over one year was conducted in a sequential sample of 34 smokers, 35 nonsmokers, and 24 ex-smokers with type I diabetes, hypertension, and diabetic nephropathy. Progression of renal disease was defined according to the stage of nephropathy as an increase in proteinuria or serum creatinine or a decrease in the glomerular filtration rate.
Progression of nephropathy was less common in nonsmokers (11%) than in smokers (53%) and patients who had quit smoking (33%), P < 0.001. In a stepwise logistic regression analysis, cigarette pack years, 24-h sodium excretion, and GHb were independent predictive factors for the progression of diabetic nephropathy. Because blood pressure (BP) was well controlled in these patients and most values were within a normotensive range, neither standing, sitting, nor supine BP values were associated with progression of nephropathy.
Cigarette smoking represents an important factor associated with progression of nephropathy in treated hypertensive type I diabetic patients.
研究吸烟与糖尿病肾病进展之间的关联。
对34名吸烟者、35名非吸烟者和24名已戒烟的I型糖尿病、高血压和糖尿病肾病患者进行了为期一年的前瞻性随访研究。根据肾病阶段,将肾病进展定义为蛋白尿或血清肌酐增加或肾小球滤过率降低。
非吸烟者(11%)的肾病进展比吸烟者(53%)和已戒烟者(33%)少见,P<0.001。在逐步逻辑回归分析中,吸烟包年数、24小时钠排泄量和糖化血红蛋白是糖尿病肾病进展的独立预测因素。由于这些患者的血压(BP)得到了良好控制,且大多数值处于正常血压范围内,因此站立、坐位或仰卧位血压值均与肾病进展无关。
吸烟是治疗的高血压I型糖尿病患者肾病进展的一个重要相关因素。